Zimhi isn't saving shareholders. It won't be able to cut through the bureaucracies anytime soon especially considering how well the nasal application has been for a LONG time. Only benefit of the needle is if you are standing next to the person as they overdose. If not, makes no difference. The large organizations who would be buying large quantities of narcan understand this and will pass on it. Its not a better mousetrap. Applying emotions to my investing won't make me money, just lose it. This is why I use the 1 minute chart for investing. LOL. eom;)
News 
Market Data 
Discover 
AI
